Discover a New Approach to Depression Treatment with SPRAVATO®

If traditional oral antidepressants have left you feeling stuck, SPRAVATO® (esketamine) nasal spray offers a different way forward. FDA-approved and designed for adults with treatment-resistant depression or depressive symptoms associated with major depressive disorder (MDD), SPRAVATO® works alongside an oral antidepressant to help improve symptoms.

This innovative treatment utilizes a unique pathway in the brain, providing a new perspective on well-being and recovery. Administered under the guidance of healthcare professionals, SPRAVATO® ensures a monitored and supportive experience tailored to your needs.

Turn to a new chapter in your mental health journey with SPRAVATO®—because brighter days are possible.